What evidence describes clear cell adenocarcinoma of the omentum or other extra-ovarian sites arising after bladder urothelial/transitional cell carcinoma or endometriosis, and what pathological evidence supports each proposed origin?

OA: green CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-09 ⓘ

This paper reviews evidence linking clear cell adenocarcinoma of the omentum or extra-ovarian sites to endometriosis and bladder urothelial carcinoma, noting that existing data primarily address endometriosis-related origins.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-05 · read from full text ⓘ

This review examines the pathological evidence linking clear cell adenocarcinoma at extra-ovarian sites, such as the omentum, to prior bladder urothelial carcinoma or endometriosis. The analysis highlights that while limited indirect evidence and case reports suggest an endometrial transformation origin from endometriosis, data connecting bladder cancer to these tumors remain sparse. The authors note a significant lack of comprehensive studies for the urothelial pathway compared to the established, albeit indirect, links with endometriosis. This paper is centrally about endometriosis — specifically its potential role as a precursor for extra-ovarian clear cell adenocarcinoma, contrasting it with less understood origins like bladder carcinoma.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Limited indirect evidence links clear cell adenocarcinoma to endometriosis, with case reports highlighting endometrial transformation. Further research is required to explore links between bladder urothelial carcinoma and extra-ovarian clear cell adenocarcinoma, as existing data primarily address endometriosis-related origins.
Full text 803 characters · extracted from oa-doi-fallback · click to expand
Published October 1, 2026 | Version v1 Other Open What evidence describes clear cell adenocarcinoma of the omentum or other extra-ovarian sites arising after bladder urothelial/transitional cell carcinoma or endometriosis, and what pathological evidence supports each proposed origin? Description Limited indirect evidence links clear cell adenocarcinoma to endometriosis, with case reports highlighting endometrial transformation. Further research is required to explore links between bladder urothelial carcinoma and extra-ovarian clear cell adenocarcinoma, as existing data primarily address endometriosis-related origins. Files 969d7b4e-b9c2-4e19-862d-654c3c12f48f.pdf Files (18.6 kB) | Name | Size | Download all | |---|---|---| | md5:9a7829002bd543dd39792f19d35d70ca | 18.6 kB | Preview Download |

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-10-06T06:07:52.081803+00:00
License: CC0 · commercial use OK